Stock 002566 JILIN JIAN YISHENG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Equities

002566

CNE1000011C3

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 16/07/2024 BST 		5-day change 1st Jan Change
6.09 CNY -0.49% Intraday chart for Jilin Jian Yisheng Pharmaceutical Co., Ltd. +0.16% -31.65%
05-13 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 CI
04-25 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Jian Yisheng Pharma Sets Up 3 Million Yuan Subsidiary
MT
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Approves Cash Dividend for 2022, Payable on 7 July 2023
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Proposes Dividend for the Year 2022
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 07, 2022
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2021
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020, Payable on May 18, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002566 Stock
  4. News Jilin Jian Yisheng Pharmaceutical Co., Ltd.
  5. Highlights